Skip to content
MedGadget – Medical Technology and Healthcare News Website Logo

MedGadget

Where Medicine Meets Technology

  • Author
  • Contact Us
  • About Us
Top Stories
Vetter Expands Commercial Fill-and-Finish Capacity with Ten New Manufacturing Lines
Vetter Expands Commercial Fill-and-Finish Capacity with Ten New Manufacturing Lines
Bristol Myers Squibb Q3 2026 results graphic about pipeline data
Posted inPharmaceutical

Bristol Myers Squibb Q3 2026 Results: What the Pipeline Data on CELMoDs and Admilparant Show

The Bristol Myers Squibb Q3 2026 results include CELMoD, admilparant and RYZ101 updates. What each result shows and what is pending.
Continue Reading
October 30, 2026
Laurus Labs Galenvs acquisition graphic about oligonucleotide technology
Posted inBio Technology

Laurus Labs Galenvs Acquisition: The Oligonucleotide and Nanoparticle Technology Behind the Deal

The Laurus Labs Galenvs acquisition buys oligonucleotide and nanoparticle skills. What the technology involves and what is not shown.
Continue Reading
October 30, 2026
Fortis Healthcare acquisition graphic about care quality in Bengaluru
Posted inHealthcare Services

Fortis Healthcare Acquisition of Suguna Hospital: What Consolidation Means for Care Quality in Bengaluru

The Fortis Healthcare acquisition adds 110 beds in north-west Bengaluru. What evidence says about hospital deals and quality.
Continue Reading
October 30, 2026
Top Categories
Healthcare IT
Healthcare IT
Medical Device
Medical Device
Pharmaceutical
Pharmaceutical
Overlapping circles graphic showing Biomapas and Pinnaxis combining regulatory and drug safety technology services
Posted inHealthcare Services

Biomapas Acquires Pinnaxis to Expand Drug Safety Technology and Consulting Capabilities

Biomapas acquires Pinnaxis, a pharmacovigilance technology firm in India and New Jersey, to expand drug safety services. Terms undisclosed.
October 8, 2026
Map graphic: Ofichem sites in Ter Apel and Uppsala linked to Kinentia Biosciences in Rensselaer, New York
Posted inPharmaceutical

Ofichem to Acquire Kinentia Biosciences to Expand Drug Substance CDMO Business in US

Ofichem agrees to acquire New York CDMO Kinentia Biosciences, adding a US drug substance site to its Dutch and Swedish network. Terms undisclosed.
October 8, 2026
Infographic: solengepras 150 mg cut Parkinson’s OFF time by 0.61 hours versus placebo in Phase 3 ARISE trial
Posted inPharmaceutical

Cerevance Reports Positive Phase 3 Results for Solengepras in Parkinson’s Disease

Cerevance says Phase 3 ARISE met its primary endpoint: solengepras cut daily OFF time by 0.61 hours versus placebo in Parkinson’s patients.
October 8, 2026
Actor Nana Patekar in 2025, with headline: Nana Patekar, actor of Parinda and Krantiveer, dies at 75
Posted inHealthcare Services

Nana Patekar, Celebrated Actor of Parinda and Krantiveer, Dies at 75 in Goa

Nana Patekar dies at 75 after a cardiac emergency in Goa. Career highlights, what is known, why a post-mortem matters and heart-attack warning signs.
October 8, 2026
MedGadget.org banner: Beactica selects BEA-28 TEAD degrader as preclinical candidate for solid tumours
Posted inPharmaceutical

Beactica Therapeutics Selects BEA-28 as Preclinical Candidate for Solid Tumours

Beactica selects BEA-28, a first-in-class TEAD degrader, for solid tumours, with data on KRAS inhibitor resistance. See the risks and next steps.
October 7, 2026
MedGadget.org banner: Italfarmaco and VeriSIM Life partner on HDAC-targeted therapies
Posted inPharmaceutical

Italfarmaco and VeriSIM Life Partner to Develop Novel HDAC-Targeted Therapies

Italfarmaco and VeriSIM Life partner on AI-driven HDAC-targeted therapies for neuromuscular, fibrotic and rare diseases in a deal worth over $100M.
October 7, 2026
MedGadget.org banner: Lundbeck reports Phase Ib results for Lu AF28996 in advanced Parkinsons disease
Posted inPharmaceutical

Lundbeck Reports Phase Ib Results for Lu AF28996 in Advanced Parkinson’s Disease

Lundbeck reports Phase Ib data for Lu AF28996 in advanced Parkinson’s: ON-time up 3.6 hours a day. What the open-label results mean and what Phase II will test.
October 7, 2026
MedGadget.org banner: Piramal opens new microbiology laboratory at its Kentucky sterile injectables site
Posted inPharmaceutical

Piramal Pharma Solutions Opens New Microbiology Laboratory at Kentucky Sterile Injectables Facility

Piramal Pharma Solutions opens a new microbiology laboratory in Lexington, Kentucky, tripling test space and targeting up to 50% faster testing.
October 7, 2026
MedGadget.org banner: RougeTx raises 58 million dollars Series A for oral HHT therapy RTX-001
Posted inPharmaceutical

RougeTx Launches with $58 Million Series A to Advance HHT Therapy RTX-001

RougeTx launches with a $58M Series A to take oral HHT therapy RTX-001 toward the clinic. Investors, how it works and what comes next.
October 7, 2026
UK MHRA continuous monitoring framework for AI medical devices featured graphic
Posted inMedical Device

UK Introduces Continuous Monitoring Framework for AI Medical Devices in Major Regulatory Shift

The UK accepts all 44 recommendations on AI regulation, moving to lifecycle monitoring of AI medical devices. What the MHRA plans, and when.
October 6, 2026

Posts pagination

Previous page 1 … 11 12 13 14 15 … 25 Next page

All Categories

  • Bio Technology
  • Healthcare IT
  • Healthcare Services
  • Life Science
  • Medical Device
  • Pharmaceutical
  • Press Releases
  • Uncategorized
Press Releases
Vetter Expands Commercial Fill-and-Finish Capacity with Ten New Manufacturing Lines
Posted inPress Releases

Vetter Expands Commercial Fill-and-Finish Capacity with Ten New Manufacturing Lines

Firefly Neuroscience and NeuroSigma Expand Access to Non-Drug Pediatric ADHD Treatment
Posted inPress Releases

Firefly Neuroscience and NeuroSigma Expand Access to Non-Drug Pediatric ADHD Treatment

InSilicoTrials Joins ARPA-H CIRCLE Program to Advance Digital Health Through Critical Care Digital Twins
Posted inPress Releases

InSilicoTrials Joins ARPA-H CIRCLE Program to Advance Digital Health Through Critical Care Digital Twins

Grünenthal and DKSH Expand Pain Medicine Partnership Across Eight Asia-Pacific Markets
Posted inPress Releases

Grünenthal and DKSH Expand Pain Medicine Partnership Across Eight Asia-Pacific Markets

Copyright 2026 — MedGadget.
Scroll to Top